Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
PHARMA EQUITY GROUP Aktie jetzt für 0€ handeln | |||||
Mi | Pharma Equity Group A/S: The Board of Directors' resolution on the issuance of convertible loans | 1 | GlobeNewswire (USA) | ||
01.09. | Pharma Equity Group A/S: Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis | 241 | GlobeNewswire (Europe) | Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis Copenhagen, September... ► Artikel lesen | |
14.08. | Pharma Equity Group A/S: Consolidated Interim Report 1 January - 30 June 2025 | 91 | GlobeNewswire (Europe) | Consolidated Interim Report 1 January - 30 June 2025Key points from the H1-2025 report (period 1 January - 30 June 2025) 14 August 2025Announcement no. 9 On 14 August 2025, the Board of Directors... ► Artikel lesen | |
01.07. | Pharma Equity Group A/S: The Board of Directors' resolution on the issuance of convertible loans | 1 | GlobeNewswire (USA) | ||
28.05. | Pharma Equity Group A/S Launches New Strategy to Drive Growth and Shareholder Returns | 352 | GlobeNewswire (Europe) | Pharma Equity Group A/S Launches New Strategy to Drive Growth and Shareholder Returns 28 May 2025Announcement no. 7 Pharma Equity Group (PEG) today announces the launch of a transformative... ► Artikel lesen | |
05.05. | Passing of the General Meeting of Pharma Equity Group A/S | 258 | GlobeNewswire (Europe) | Passing of the General Meeting of Pharma Equity Group A/S
5th of May 2025Company Announcement no. 6
The chairman of the meeting reviewed the agenda for today's general meeting, which was: The Board... ► Artikel lesen | |
20.03. | Pharma Equity Group A/S - Annual Report 2024 | 195 | GlobeNewswire (Europe) | Pharma Equity Group A/S - Annual Report 2024 Date: 20 March 2025 Announcement No. 2 Pharma Equity Group A/S - Annual Report 2024 - main features of the year The Board of Directors of Pharma Equity Group... ► Artikel lesen | |
13.12.24 | Pharma Equity Group A/S: The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S. | 113 | GlobeNewswire (Europe) | The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S. December 13, 2024Announcement No. 32 Pharma Equity Group... ► Artikel lesen | |
15.11.24 | Pharma Equity Group A/S: Consolidated Interim report 1 January - 30 September 2024 | 152 | GlobeNewswire (Europe) | Consolidated Interim report 1 January - 30 September 2024 Company announcement no. 30 - November 15, 2024 Key points from the Q1-Q3-2024 report (period 1 January - 30 September 2024) On 15 November... ► Artikel lesen | |
23.10.24 | Pharma Equity Group A/S: Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. | 135 | GlobeNewswire (Europe) | Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. October 23, 2024Company Announcement... ► Artikel lesen | |
11.10.24 | Nasdaq Copenhagen A/S: Pharma Equity Group A/S - admittance to trading and official listing of new shares due to a directed issue | 356 | GlobeNewswire | The share capital of Pharma Equity Group A/S has been increased. The admittance
to trading and official listing of new shares will take effect as per 16
October 2024 in the ISIN below.
ISIN ... ► Artikel lesen | |
04.10.24 | Nasdaq Copenhagen A/S: Pharma Equity Group A/S - reduction of share capital by reduction of face value per share | 225 | GlobeNewswire | The changes below will take effect on Nasdaq Copenhagen as per 10 October 2024.
ISIN DK0061155009
--------------------------------------------------------------------------------
Name:... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ISHARES BITCOIN TRUST | 68,76 | 0,00 % | Blackrocks IBIT überholt Deribit als größter Bitcoin-Optionsplatz der Welt | ||
ALLIANZ | 363,00 | +0,19 % | Allianz-Aktie: Bestens versichert - starker Dividendenwert mit neuem Wachstumspotenzial | Der Versicherungsriese lag zur Halbzeit bereits über Plan. Ein starkes Prämienwachstum und ein kräftiges Neugeschäft beflügeln die Entwicklung. Die Aktie der Allianz war mit der überdurchschnittlich... ► Artikel lesen | |
COMMERZBANK | 33,080 | +2,64 % | Commerzbank Aktie: Die Wende? - ASML, BYD, Gerresheimer, Hensoldt und Verbio im Marktbericht Börse Frankfurt | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
DEUTSCHE BANK | 30,405 | +1,20 % | Aktienmarkt: Kurs der Deutsche Bank-Aktie im Plus (30,355 €) | Am deutschen Aktienmarkt liegt die Aktie der Deutschen Bank zur Stunde im Plus. Der jüngste Kurs betrug 30,36 Euro. Für die Deutsche Bank-Aktie steht gegenwärtig ein Kursplus 0,66 Prozent zu Buche.... ► Artikel lesen | |
MUENCHENER RUECK | 552,50 | -0,09 % | EQS-DD: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Dr. Christoph Jurecka, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
26.09.2025 / 10:53... ► Artikel lesen | |
DEUTSCHE BOERSE | 228,20 | -1,17 % | Deutsche Börse-Aktie: Kurs legt zu (225,30 €) | Im Plus liegt gegenwärtig das Wertpapier von Deutschen Börse . Der jüngste Kurs betrug 225,30 Euro. Ein Plus in Höhe von 1,20 Euro erfreut derzeit die Aktionäre von Deutschen Börse. Die Aktie notierte... ► Artikel lesen | |
THE BANCORP | 74,62 | 0,00 % | Aktie von The Bancorp Inc. erreicht Rekordhoch von 80,19 USD | ||
GRAYSCALE ETHEREUM MINI TRUST | 42,360 | 0,00 % | Grayscale Ethereum Mini Trust ETF: Index-Zusammensetzung zur Preisberechnung angepasst | ||
GRAYSCALE ETHEREUM TRUST | 37,050 | 0,00 % | Grayscale Ethereum Trust ETF - 8-K, Current Report | ||
PAGAYA TECHNOLOGIES | 31,090 | 0,00 % | Pagaya Technologies Ltd. - 8-K, Current Report | ||
BLUE OWL CAPITAL | 16,050 | 0,00 % | Blue Owl Capital's Growth Story: Solid Portfolio, Shaky Efficiency? | ||
COMMERCIAL BANCGROUP | 24,000 | 0,00 % | Commercial Bancgroup, Inc. Announces Pricing of Upsized Initial Public Offering | HARROGATE, TENNESSEE / ACCESS Newswire / October 1, 2025 / Commercial Bancgroup, Inc. ("Commercial"), a Tennessee corporation and the bank holding company for Commercial Bank, a Tennessee state-chartered... ► Artikel lesen | |
FIDELITY WISE ORIGIN BITCOIN FUND | 105,60 | 0,00 % | Fidelity Wise Origin Bitcoin Fund - 10-Q, Quarterly Report | ||
ROOT INSURANCE | 90,97 | 0,00 % | Root, Inc. (ROOT): A Bull Case Theory | ||
UNITED STATES NATURAL GAS FUND | 13,440 | 0,00 % | United States Natural Gas Fund, LP - 8-K, Current Report |